Given rising scrutiny of healthcare expenditures, understanding intervention costs is increasingly important. This study aimed to compare and characterize costs for vestibular schwannoma (VS) management with microsurgery and radiosurgery to inform practice decisions and appraise cost reduction strategies.
In conjunction with medical records, internal hospital financial data were used to evaluate costs. Total cost was divided into index costs (costs from arrival through discharge for initial intervention) and follow-up costs (through 36 months) for 317 patients with unilateral VSs undergoing initial management between June 2011 and December 2015. A retrospective matched cohort based on tumor size with 176 patients (88 undergoing each intervention) was created to objectively compare costs between microsurgery and radiosurgery. The full sample of 203 patients treated with resection and 114 patients who underwent radiosurgery was used to evaluate a broad range of outcomes and identify cost contributors within each intervention group.
Within the matched cohort, average index costs were significantly higher for microsurgery (100% by definition, because costs are presented as a percentage of the average index cost for the matched microsurgery group; 95% CI 93–107) compared to radiosurgery (38%, 95% CI 38–39). Microsurgery had higher average follow-up costs (1.6% per month, 95% CI 0.8%–2.4%) compared to radiosurgery (0.5% per month, 95% CI 0.4%–0.7%), largely due to costs incurred in the initial months after resection. A major contributor to total cost and cost variability for both resection and radiosurgery was the need for additional interventions in the follow-up period, which were necessary due to complications or persistent functional deficits. Although tumor size was not associated with increased total costs for radiosurgery, linear regression analysis demonstrated that, for patients who underwent microsurgery, each centimeter increase in tumor maximum diameter resulted in an estimated increase in total cost of 50.2% of the average index cost of microsurgery (95% CI 34.6%–65.7%) (p < 0.001, R2 = 0.17). There were no cost differences associated with the proportion of inpatient days in the ICU or with specific surgical approach for patients who underwent resection.
This study is the largest assessment to date based on internal cost data comparing VS management with microsurgery and radiosurgery. Both index and follow-up costs are significantly higher when tumors were managed with resection compared to radiosurgery. Larger tumors were associated with increased resection costs, highlighting the incremental costs associated with observation as the initial management.
ABBREVIATIONSBAHA = bone-anchored hearing aid; EMR = electronic medical record; LOS = length of stay; PTA = pure tone average; SDS = speech discrimination score; SRS = stereotactic radiosurgery; VS = vestibular schwannoma.
ArunachalamPS, KilbyD, MeikleD, DavisonT, JohnsonIJ: Bone-anchored hearing aid quality of life assessed by Glasgow Benefit Inventory. 111:1260–1263, 200110.1097/00005537-200107000-0002211568551)| false
BanerjeeRMoriartyJPFooteRLPollockBE: Comparison of the surgical and follow-up costs associated with microsurgical resection and stereotactic radiosurgery for vestibular schwannoma. J Neurosurg108:1220–12242008
BanerjeeR, MoriartyJP, FooteRL, PollockBE: Comparison of the surgical and follow-up costs associated with microsurgical resection and stereotactic radiosurgery for vestibular schwannoma. 108:1220–1224, 20081851873110.3171/JNS/2008/108/6/1220)| false
BreivikCNNilsenRMMyrsethEPedersenPHVarugheseJKChaudhryAA: Conservative management or gamma knife radiosurgery for vestibular schwannoma: tumor growth, symptoms, and quality of life. Neurosurgery73:48–572013
GaitC, FrewEJ, MartinTP, JowettS, IrvingR: Conservative management, surgery and radiosurgery for treatment of vestibular schwannomas: a model-based approach to cost-effectiveness. 39:22–31, 201410.1111/coa.1220524313969)| false
GolfinosJGHillTCRokoshRChoudhryOShinsekiMMansouriA: A matched cohort comparison of clinical outcomes following microsurgical resection or stereotactic radiosurgery for patients with small- and medium-sized vestibular schwannomas. J Neurosurg125:1472–14822016
GolfinosJG, HillTC, RokoshR, ChoudhryO, ShinsekiM, MansouriA, : A matched cohort comparison of clinical outcomes following microsurgical resection or stereotactic radiosurgery for patients with small- and medium-sized vestibular schwannomas. 125:1472–1482, 20162703517410.3171/2015.12.JNS151857)| false
International RadioSurgery Association: Radiosurgery Practice Guideline Initiative. Stereotactic Radiosurgery for Patients with Vestibular Schwannomas. Harrisburg, PA: ISRA2006(http://www.irsa.org/AN%20Guideline.pdf) [Accessed July 17 2018]
. Harrisburg, PA: ISRA, 2006(http://www.irsa.org/AN%20Guideline.pdf) [Accessed July 17, 2018])| false
KahnJM, RubenfeldGD, RohrbachJ, FuchsBD: Cost savings attributable to reductions in intensive care unit length of stay for mechanically ventilated patients. 46:1226–1233, 200810.1097/MLR.0b013e31817d934219300312)| false
MyrsethEMøllerPPedersenPHVassbotnFSWentzel-LarsenTLund-JohansenM: Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery. Neurosurgery56:927–9352005
MyrsethE, MøllerP, PedersenPH, VassbotnFS, Wentzel-LarsenT, Lund-JohansenM: Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery. 56:927–935, 200515854240)| false
PollockBEDriscollCLFooteRLLinkMJGormanDABauchCD: Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery59:77–852006
SonigAKhanISWadhwaRThakurJDNandaA: The impact of comorbidities, regional trends, and hospital factors on discharge dispositions and hospital costs after acoustic neuroma microsurgery: a United States nationwide inpatient data sample study (2005–2009). Neurosurg Focus33(3):E32012
SonigA, KhanIS, WadhwaR, ThakurJD, NandaA: The impact of comorbidities, regional trends, and hospital factors on discharge dispositions and hospital costs after acoustic neuroma microsurgery: a United States nationwide inpatient data sample study (2005–2009). 33(3):E3, 20122293785410.3171/2012.7.FOCUS12193)| false
ZygourakisCCOhTSunMZBaraniIKahnJGParsaAT: Surgery is cost-effective treatment for young patients with vestibular schwannomas: decision tree modeling of surgery, radiation, and observation. Neurosurg Focus37(5):E82014
ZygourakisCC, OhT, SunMZ, BaraniI, KahnJG, ParsaAT: Surgery is cost-effective treatment for young patients with vestibular schwannomas: decision tree modeling of surgery, radiation, and observation. 37(5):E8, 201410.3171/2014.8.FOCUS1443526218621)| false